XML 30 R21.htm IDEA: XBRL DOCUMENT v3.10.0.1
Reportable Segments
 6 Months Ended
Jun. 30, 2018
Segment Reporting [Abstract]  
Reportable Segments
Reportable Segments
The structure of our internal organization is divided into the following reportable segments, which are also our operating segments: E&C, D&S, and BioMedical. Corporate includes operating expenses for executive management, accounting, tax, treasury, corporate development, human resources, information technology, investor relations, legal, internal audit, and risk management. Corporate support functions are not currently allocated to the segments.
The following table represents information for our reportable segments and our corporate function:
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2018
 
2017
 
2018
 
2017
Sales
 
 
 
 
 
 
 
Energy & Chemicals (1)
$
100.8

 
$
40.0

 
$
190.7

 
$
79.9

Distribution & Storage
157.4

 
137.6

 
293.5

 
250.8

BioMedical
62.0

 
60.6

 
116.7

 
111.6

Intersegment eliminations
(0.3
)
 
—

 
(1.3
)
 
—

Consolidated
$
319.9

 
$
238.2

 
$
599.6

 
$
442.3

Operating Income (Loss) (2)
 
 
 
 
 
 
 
Energy & Chemicals (1)
$
5.9

 
$
(2.5
)
 
$
8.7

 
$
(2.7
)
Distribution & Storage
24.8

 
16.6

 
42.9

 
28.2

BioMedical (3)
8.5

 
9.8

 
18.0

 
14.8

Corporate (4) (5)
(15.7
)
 
(14.0
)
 
(29.2
)
 
(30.1
)
Consolidated
$
23.5

 
$
9.9

 
$
40.4

 
$
10.2

 _______________
(1) 
Hudson, included in the E&C segment results since the acquisition date, September 20, 2017, added net sales and operating income of:
•
$47.5 and $6.1 for the three months ended June 30, 2018, respectively, and
•
$90.8 and $10.3 for the six months ended June 30, 2018, respectively.
(2) 
Includes restructuring costs of:
•
$0.6 and $5.0 for the three months ended June 30, 2018 and 2017 respectively, and
•
$1.5 and $9.6 for the six months ended June 30, 2018 and 2017 respectively.
(3) 
Includes an expense of $3.8 recorded to cost of sales related to the estimated costs of the aluminum cryobiological tank recall for the three and six months ended June 30, 2018.
(4) 
Includes transaction-related costs of:
•
$0.8 and $1.0 for the three months ended June 30, 2018 and 2017, respectively, and
•
$2.1 and $1.1 for the six months ended June 30, 2018 and 2017, respectively.
(5) 
Includes net severance costs of $1.4 related to the departure of our former CEO on June 11, 2018, which includes $3.2 in payroll severance costs partially offset by a $1.8 credit due to related share-based compensation forfeitures for the three and six months ended June 30, 2018.